Safety and Efficacy Study of Neratinib and Cetuximab to Treat Patients With Quadruple Wild-Type Metastatic Colorectal Cancer
Clinical trial NCT01960023 · WITHDRAWN
Trial details
- NCT number
- NCT01960023
- Sponsor
- NSABP Foundation Inc
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2016-07-13
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.